Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2000
09/28/2000WO2000056348A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000WO2000056331A1 Inhibitors of impdh enzyme
09/28/2000WO2000056306A1 Treatment of osteoarthritis
09/28/2000WO2000056283A1 Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
09/28/2000WO2000056275A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration
09/28/2000WO2000056164A1 Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000022142A3 Cell signaling polypeptides and nucleic acids
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2512479A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2512291A1 Pro4356 polypeptides and nucleic acids encoding the same
09/28/2000CA2510982A1 Lectin-like protein, pro1890, encoding nucleic acids, pro1890 antibodies and uses thereof
09/28/2000CA2510931A1 Pro4334 polypeptides and nucleic acids
09/28/2000CA2510806A1 Screted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2368041A1 Indolinone compounds as kinase inhibitors
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367699A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367132A1 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
09/28/2000CA2366660A1 Treatment of osteoarthritis
09/28/2000CA2365405A1 Human tumor necrosis factor receptor-like 2
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2364847A1 Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037994A1 Peptide antagonists of vascular endothelial growth factor
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037981A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
09/27/2000EP1037970A1 Secreted proteins and polynucleotides encoding them
09/27/2000EP1037915A1 Matrix-remodeling genes
09/27/2000EP1037908A2 Human tumor necrosis factor-r2-like proteins
09/27/2000EP1037906A1 Cyclopeptide derivatives with integrin inhibitor properties
09/27/2000EP1037660A1 ribB
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037654A1 ribA
09/27/2000EP1037651A1 Small peptides and methods for treatment of asthma and inflammation
09/27/2000EP1005351A4 An aqueous metal bicarbonate solution and method of use
09/27/2000EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor
09/27/2000CN1268133A 2-Aminopyridines containing fused ring substituents as NOS inhibitors
09/27/2000CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1268112A Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
09/27/2000CN1268057A Cross-linked polysaccharide drug carrier
09/27/2000CN1267531A Preparation and use of external-use medicine for cardiac and cerebral vascular diseases and rheumatism
09/27/2000CN1267526A Compound Chinese medicine preparation for treating hyperosteogeny
09/27/2000CN1056851C Cyclic adhesion inhibitors
09/27/2000CN1056769C Osteopathy capsule and preparing technology
09/27/2000CN1056767C Medical composition for treating bone spur
09/27/2000CN1056754C Hot compress plaster for curing rheumatism
09/26/2000US6124358 Pharmaceutical composition containing rhein or diacerhein with improved bioavailability
09/26/2000US6124314 Osteoporosis compounds
09/26/2000US6124299 Calcitonin mimetics
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124264 Growth hormone secretagogue in a human or other animal to treat osteoporosis, congestive heart failure, aging, obesity; bone and wound healing agents
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124095 Human nucleotide pyrophosphohydrolase-2
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055118A1 Nuclear receptor arylating compounds
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055109A1 Lipoxin compounds and their use
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
09/21/2000WO2000054801A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054780A2 Corticosteroid formulation
09/21/2000WO2000054769A1 Protease inhibitors
09/21/2000WO2000054763A2 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
1 ... 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 ... 820